Your session is about to expire
← Back to Search
Behavioral Intervention
Yoga for Cardiovascular Disease
N/A
Recruiting
Research Sponsored by Geunyeong Cha
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
have a history of an acute myocardial infarction within the preceding year, stable angina, cardiac surgery (including heart transplantation, valve surgery, or coronary artery bypass), coronary artery angioplasty or stents, or heart failure (ejection fraction < 35%) diagnosed in the past year
History of an acute myocardial infarction within the preceding year, stable angina, cardiac surgery (including heart transplantation, valve surgery, or coronary artery bypass), coronary artery angioplasty or stents, or heart failure (ejection fraction < 35%) diagnosed in the past year
Must not have
Incapacitating neurologic, orthopedic, or neoplastic conditions such as stroke paralysis, terminal cancer, or a cognitive disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and three months
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying the effects of yoga on the physical and psychological health of older adults with cardiovascular disease. The researchers want to see if participating in yoga classes twice a week for three months can improve things
Who is the study for?
This trial is for older adults over 65 with cardiovascular disease who have had a heart attack, stable angina, cardiac surgery, or heart failure in the past year. They should have finished a cardiac rehab program recently and be able to do yoga without other major health issues interfering.
What is being tested?
The study tests if gentle yoga can improve physical functions like balance and muscle strength, as well as reduce depressive symptoms and anxiety in older cardiac patients. Participants will attend yoga sessions twice weekly for three months.
What are the potential side effects?
Yoga is generally safe but may include risks of muscle strains or falls for some individuals. It's important that participants communicate any discomfort they experience during the practice.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a heart attack, heart surgery, or diagnosed heart failure in the last year.
Select...
I have had a heart attack, heart surgery, or been diagnosed with heart failure in the last year.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have severe conditions like stroke paralysis, terminal cancer, or cognitive disorders.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and three months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and three months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Intervention acceptability
Intervention adherence rate
Intervention satisfaction
+2 moreSecondary study objectives
Change in Balance
Change in Brief Symptom Inventory
Change in Muscle strength
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Online Yoga InterventionExperimental Treatment1 Intervention
Participants in the intervention group will attend two virtual 60-minute gentle yoga sessions per week for 12 weeks.
Group II: ControlActive Control1 Intervention
Participants in the control group will not receive any intervention but will be provided with printed or electronic versions of the American Heart Association's 'Life's Essential 8' at baseline, which includes information on how to improve and maintain cardiovascular health.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gentle Yoga
2022
N/A
~10
Find a Location
Who is running the clinical trial?
Geunyeong ChaLead Sponsor
Debra K Moser, Ph.DStudy ChairUniversity of Kentucky